Securing the Supply Chain: Third-Party Contingency Planning for Clinical Trial Transport

It's a transformational moment, that moment when the first shipment of IMPs and clinical trial materials leave the production facility in the hands of an outside transport or logistics provider. It is the moment when years of research, analysis and preparation exit the protective custody of the laboratory to be shaped by the real world. In these volatile times, are you certain that your logistics provider can effectively respond to the many unexpected occurrences that threaten to disrupt your carefully conceived budget and timetable?

Download this free white paper to find out more.